No Data
TALENT PPT GP (00760.HK) will hold a Board of Directors meeting on March 28 to approve the annual performance.
Gelonghui reported on March 13 that TALENT PPT GP (00760.HK) announced that the Board of Directors will hold a meeting on March 28, 2025, to approve the release of the annual performance announcement for the company and its subsidiaries for the year ending December 31, 2024.
Insiders Were the Biggest Winners as Newland Pharmaceutical Co., Ltd.'s (SZSE:301277) Market Cap Grew by CN¥370m Last Week
Xintiandi: 2024 Annual Report Summary
Xintiandi: 2024 Annual Report
Xintiandi (301277.SZ) released its 2024 annual performance, with a net income of 0.174 billion yuan, a year-on-year increase of 9.22%, and plans to distribute 4 yuan and convert 4 shares for every 10 shares.
Xintiandi (301277.SZ) released its annual report for 2024, with the company's annual revenue for 2024 being 7....
Xintiandi (301277.SZ): In 2024, Net income is expected to grow by 9.22% year-on-year, planning to distribute 4 yuan per 10 shares.
On March 10, 2024, Gelonghui announced that New World (301277.SZ) published its annual report for 2024. During the reporting period, the company further strengthened internal management, adhered to cost reduction and efficiency improvement, achieving revenue of 726.437 million yuan, a year-on-year increase of 11.51%, and net income attributable to shareholders of the listed company was 173.6292 million yuan, up 9.22% year-on-year. A cash dividend of 4 yuan per 10 shares will be distributed to all shareholders, and a capital reserve will be converted into 4 additional shares for every 10 shares to all shareholders. The company is currently a major global producer of L-threo-hydroxyphenylalanine and a key domestic producer of p-toluenesulfonic acid.
